Fate Therapeutics (FATE) EBT Margin Growth (1y) (2013 - 2026)
Fate Therapeutics (FATE) EBT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - | -106,599.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106,599.00 |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 217,820.00 |
| Jun 30, 2025 | 53,489.00 |
| Mar 31, 2025 | -489,545.00 |
| Dec 31, 2024 | -64,384.00 |
| Sep 30, 2024 | 446,027.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -525,585.00 |
| Dec 31, 2023 | -2.11 Mn |
| Sep 30, 2023 | -992,666.00 |
| Jun 30, 2023 | -1.16 Mn |
| Mar 31, 2023 | 33,483.00 |
| Dec 31, 2022 | 92,684.00 |
| Sep 30, 2022 | 66,403.00 |
| Jun 30, 2022 | -49,420.00 |
| Mar 31, 2022 | 66,865.00 |
| Dec 31, 2021 | -61,923.00 |
| Sep 30, 2021 | 127,726.00 |
| Jun 30, 2021 | 313,484.00 |